Communicable Disease Control and Health Protection Handbook

Author: Jeremy Hawker

$140.00

0 Units in Stock

Add to Cart:

 
  • ISBN: 9781444335675
  • Author: Jeremy Hawker
  • Publ Date: 2012-02-20
  • Edition: 3
  • Pages: 456
  • Imprint: BLACKWELL *#
  • Status: ACT
  • ID - 13918

Table of Contents :

Foreword.
Abbreviations.
Section 1: Introduction.
1.1 How to use this book.
1.2 Basic Concepts in the Epidemiology and Control of InfectiousDisease.
1.3 Health Protection on-call.
Section 2: Common topics.
2.1 Meningitis and meningism.
2.2 Gastrointestinal infection.
2.3 Community acquired pneumonia.
2.4 Rash in pregnancy.
2.5 Rash and fever in children.
2.6 Illness in returning travellers.
2.7 Sexually Transmitted Infections.
2.8 Jaundice.
2.9 Infection in the immunocompromised.
2.10 Blood borne viral infections.
2.11 Vaccine Queries.
2.12 Individual measures against infections.
Section 3: Diseases.
3.1 Amoebic dysentery.
3.2 Anthrax.
3.3 Bacillus cereus.
3.4 Botulism.
3.5 Brucellosis.
3.6 Burkholderia.
3.7 Campylobacter.
3.8 Chickenpox and shingles (varicella-zoster infections).
3.9 Chikungunya.
3.10 Chlamydophila pneumoniae.
3.11 Chlamydophila psittaci.
3.12 Chlamydia trachomatis (genital).
3.13 Cholera.
3.14 CJD and other human transmissible spongiformencephalopathies.
3.15 Clostridium difficile.
3.16 Clostridium perfringens.
3.17 Coxsackievirus infections.
3.18 Cryptosporidiosis.
3.19 Cyclosporiasis.
3.20 Cytomegalovirus.
3.21 Dengue fever.
3.22 Diphtheria.
3.23 Encephalitis, acute.
3.24 Enterococci, including glycopeptide-resistant enterococci(GRE).
3.25 Epstein Barr virus.
3.26 Escherichia coli O157 (and other E. coligastroenteritis).
3.27 Giardiasis.
3.28 Gonorrhoea, syphilis and other acute STIs.
3.29 Hantavirus.
3.30 Head lice.
3.31 Helicobacter pylori.
3.32 Hepatitis A.
3.33 Hepatitis B.
3.34 Hepatitis C.
3.35 Delta hepatitis.
3.36 Hepatitis E.
3.37 Herpes simplex.
3.38 Haemophilus influenzae type b (Hib).
3.39 HIV.
3.40 Influenza.
3.41 Japanese B encephalitis.
3.42 Kawasaki Syndrome.
3.43 Legionellosis.
3.44 Leprosy.
3.45 Leptospirosis.
3.46 Listeria.
3.47 Lyme disease.
3.48 Malaria.
3.49 Measles.
3.50 Meningococcal infection.
3.51 Molluscum contagiosum.
3.52 MRSA (methicillin-resistant Staphylococcus aureus).
3.53 Mumps.
3.54 Mycoplasma.
3.55 Norovirus.
3.56 Paratyphoid fever.
3.57 Parvovirus B19 (fifth disease).
3.58 Plague.
3.59 Pneumococcal infection.
3.60 Poliomyelitis.
3.61 Q fever.
3.62 Rabies.
3.63 Relapsing Fever.
3.64 Respiratory syncytial virus (RSV).
3.65 Ringworm.
3.66 Rotavirus.
3.67 Rubella.
3.68 Salmonellosis.
3.69 Severe Acute Respiratory Syndrome (SARS).
3.70 Scabies
3.71 Shigella.
3.72 Smallpox.
3.73 Staphylococcal food poisoning.
3.74 Streptococcal infections.
3.75 Tetanus.
3.76 Threadworms.
3.77 Tick-borne encephalitis.
3.78 Toxocara.
3.79 Toxoplasmosis.
3.80 Tuberculosis.
3.81 Tularaemia.
3.82 Typhoid fever.
3.83 Rickettsial infections (incl. Typhus) Ehrlichia andBartonella.
3.84 Vibrio parahaemolyticus.
3.85 Viral haemorrhagic fevers.
3.86 Warts and verrucae.
3.87 West Nile Virus.
3.88 Whooping cough.
3.89 Yellow fever.
3.90 Yersiniosis.
3.91 Other organisms.
Section 4: Services and organisations.
4.1 Surveillance of communicable disease.
4.2 Managing infectious disease incidents and outbreaks.
4.3 Infection Prevention and Control in the Community.
4.4 Healthcare Associated Infection.
4.5 Antimicrobial Resistance.
4.6 Risks to and from Health Care Workers.
4.7 Co-ordination of immunisation services.
4.8 Services for sexual health and HIV infection.
4.9 Services for tuberculosis control.
4.10 Travel Health.
4.11 Pandemic Preparedness and the Influenza A H1N1 2009Pandemic.
4.12 Non-infectious environmental hazards.
4.13 Managing acute chemical incidents.
4.14 Managing acute radiation incidents.
4.15 Deliberate release of biological, chemical or radiologicalagents.
4.16 Media Relations and Crisis Communication.
4.17 Clinical Governance and Audit.
4.18 Global health.
Section 5: Communicable disease control in Europe.
5.1 WHO and International Health Regulations (IHR).
5.2 Collaboration within the European Union.
5.3 Detailed national example: organisational arrangements forhealth protection: England, 2010.
5.4 Austria.
5.5 Belgium.
5.6 Bulgaria.
5.7 Cyprus.
5.8 Czech Republic.
5.9 Denmark.
5.10 Estonia.
5.11 Finland.
5.12 France.
5.13 Germany.
5.14 Greece.
5.15 Hungary.
5.16 Iceland.
5.17 Ireland.
5.18 Italy.
5.19 Latvia.
5.20 Lithuania.
5.21 Luxembourg.
5.22 Malta.
5.23 The Netherlands.
5.24 Norway.
5.25 Poland.
5.26 Portugal.
5.27 Romania.
5.28 Slovakia.
5.29 Slovenia.
5.30 Spain.
5.31 Sweden.
5.32 Switzerland.
5.33 United Kingdom.
Appendix 1 Useful addresses and telephone numbers.
Appendix 2 Guidance documents and books.
Index.

Description:

Health protection professionals need rapid access to authoritativeand easy-to-use information to ensure their actions are based oninternational best practice. This is precisely what the Communicable Disease Control and Health Protection Handbookdoes. This concise and practical handbook is an essential guide forall those who have responsibility for the identification andcontrol of infectious disease.

In the past five years, there have been many major changes inhealth protection practice, and significant scientific progress inthe field, all of which are reflected in this new edition of thepopular Communicable Disease Control and Health ProtectionHandbook. All chapters have been updated in line with recentchanges in epidemiology, new guidelines for control andadministrative changes. Basic principles of communicable diseasecontrol and health protection, major syndromes, control ofindividual infections, main services and activities, organizationalarrangements for all EU countries and sources of furtherinformation are covered. A new chapter on pandemic planning hasbeen included, and the influenza chapter has been expanded to coverseasonal, avian and pandemic flu.

Communicable Disease Control and Health ProtectionHandbook is an indispensible companion for all those who areengaged in health protection, including public health physicians,epidemiologists, infection control nurses, microbiologists andtrainees in the field.


Author Biography:

Jeremy Hawker is Regional Epidemiologist for the HealthProtection Agency, West Midlands; Registrar of the UK Faculty ofPublic Health, UK
Norman Begg is Chief Medical Officer, GlaxoSmithKlineBiologicals, Wavre, Belgium
Iain Blair is Associate Professor, Department ofCommunity Medicine, Faculty of Medicine and Health Sciences, UnitedArab Emirates University
Ralf Reintjes is Professor of Epidemiology and PublicHealth Surveillance, Hamburg, Germany; Adjunct Professor ofInfectious Disease Epidemiology, Tampere, Finland
Julius Weinberg is Vice Chancellor, Kingston University,London, UK
Professor Karl Ekdahl is Head of Public Health Capacityand Communication Unit, European Centre for Disease Prevention andControl (ECDC), Stockholm, Sweden


 

Estimated Delivery Times
In stock items despatched next working day
Out of stock items -locally sourced 2-5 days overseas 6-12 days
(if in stock at publisher)

Your IP Address is: 54.166.232.243
Copyright © 2003-2014 Medicalbooks Shopping Cart